Leading CRO Quintiles prices upsized IPO at $40 high end

Comment

Shutterstock photo

Quintiles Transnational, the world's largest CRO and provider of commercial outsourcing services to biopharmas, raised $947 million by offering 23.7 million shares (45% insider) at $40, the high end of the range of $36 to $40. Insider shares represented 100% of the increase in the number of shares offered. Quintiles Transnational plans to list on the NYSE under the symbol "Q". Morgan Stanley, Barclays and J.P. Morgan acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com